Breast Cancer
Latest News
Black women have higher state-level rates of TNBC
The state-level disparities highlight gaps in physicians’ understanding of how social factors contribute to disparities in TNBC risk.
From the Journals
Breast cancer surgery timing matters, but is faster always better?
There are no national quality metrics delineating optimal breast cancer surgery timing.
Latest News
HER2-low breast cancer is not a separate clinical entity: Study
Much attention has been focused recently on the idea that breast cancer with a low expression of HER2 can be treated with HER2-targeted agents,...
News from the FDA/CDC
FDA expands abemaciclib use in high-risk early breast cancer
The new expansion removes the Ki-67 testing requirement.
From the Journals
Who’s at higher risk for breast cancer recurrence?
New research shows that patients with ER-negative disease have a higher risk of a second breast cancer within a 5-year window post diagnosis,...
Feature
Myths about smoking, diet, alcohol, and cancer persist
A new study shows how thinking has changed over time and how difficult it is to alter preconceived notions.
From the Journals
Real-world survival benefit with CDK4/6 inhibitors in MBC
Treatment with endocrine therapy alone “should have a limited role in early lines of therapy for patients with HR+/HER2– MBC.”
Feature
New cancer screen, same issues: Physicians confront Galleri test
“Cancer screening is a very complicated issue. Being honest, the tests are good but are not ready yet [for wider use].”
Latest News
‘Financial toxicity’ from breast cancer is a worldwide phenomenon
It’s highest in less-developed countries, with about a third of patients affected in the U.S.
Clinical Review
Progress in breast cancer screening over the past 50 years: A remarkable story, but still work to do
Expert perspective on the myriad factors that play a role in breast cancer screening recommendations and the guidelines to consider when engaging...
From the Journals
Omit radiation in older women with low-risk, ER+ breast cancer
Trial randomly assigns 1,326 women who had undergone a lumpectomy to either whole-breast irradiation or no radiation on a background of tamoxifen...